JFL Life Sciences Ltd

NSE: JFLLIFE · Pharmaceuticals & Biotechnology · 12 announcements

Share price: ₹10.25
Market cap: ₹67.64 Cr
Revenue (annual): ₹131.4 Cr
Net profit (annual): ₹6.40 Cr
P/E (TTM): 10.6×Sector 47.4×
Promoter holding: 67.47%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 4 Other Announcement 2 Management Change 2 Board Meeting Date 2 Annual General Meeting 2

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

13 Apr 2026 23:21 IST NSE

Other Announcement

JFL Life Sciences Other Announcement

JFL Life Sciences Limited submitted its Structured Digital Database (SDD) compliance certificate for FY 2025-26. Certified by Prachi Lad & Associates, the report confirms the company captured all 8 required UPSI events, though 5 were delayed. This filing ensures transparency regarding the company's internal controls for preventing insider trading.

Read the filing ↗

4 Apr 2026 17:05 IST NSE

Other Announcement

JFL Life Sciences Other Announcement

JFL Life Sciences Limited submitted its quarterly compliance certificate under Regulation 74(5) of SEBI Regulations for the period ended March 31, 2026. The report confirms the processing of dematerialization and rematerialization requests by its registrar, KFin Technologies Limited.

Read the filing ↗